BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,374,000 | -28.2% | 35,549 | -30.8% | 0.19% | -9.4% |
| Q2 2022 | $7,484,000 | +4697.4% | 51,361 | +2313.6% | 0.21% | +2266.7% |
| Q2 2020 | $156,000 | -37.3% | 2,128 | -53.5% | 0.01% | 0.0% |
| Q4 2019 | $249,000 | +352.7% | 4,581 | +243.4% | 0.01% | +350.0% |
| Q3 2019 | $55,000 | -93.6% | 1,334 | -93.3% | 0.00% | -95.2% |
| Q2 2019 | $866,000 | +95.5% | 19,769 | +129.8% | 0.04% | +68.0% |
| Q1 2019 | $443,000 | +5437.5% | 8,603 | +3977.3% | 0.02% | – |
| Q3 2018 | $8,000 | -99.2% | 211 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $1,023,000 | – | 39,700 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |